Class III  -Tubulin Isotype Predicts Response in Advanced...

Clinical Cancer Research 2008 / 07 Vol. 14; Iss. 14

Class III  -Tubulin Isotype Predicts Response in Advanced Breast Cancer Patients Randomly Treated Either with Single-Agent Doxorubicin or Docetaxel

Galmarini, C. M., Treilleux, I., Cardoso, F., Bernard-Marty, C., Durbecq, V., Gancberg, D., Bissery, M.-C., Paesmans, M., Larsimont, D., Piccart, M. J., Di Leo, A., Dumontet, C.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
14
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.ccr-07-4741
Date:
July, 2008
File:
PDF, 625 KB
english, 2008
Conversion to is in progress
Conversion to is failed